Dynamic microscopic imaging and molecular characterisation of alveolar macrophage drug effects of a labelled inflammasome inhibitor in the human lung
T. Quinn (Edinburgh, United Kingdom), A. Pellicoro (Edinburgh, United Kingdom), C. Lochenie (Edinburgh, United Kingdom), E. Duffy (Edinburgh, United Kingdom), R. O'Connor (Edinburgh, United Kingdom), A. Fernando (Edinburgh, United Kingdom), H. Stewart (Edinburgh, United Kingdom), E. Gaughan (Edinburgh, United Kingdom), K. Finlayson (Edinburgh, United Kingdom), A. Mansell (Melbourne, Australia), C. Murphy (Concord, United States), A. Rossi (Edinburgh, United Kingdom), K. Dhaliwal (Edinburgh, United Kingdom)
Source: International Congress 2022 – Emerging therapeutic targets, biomarkers and mechanisms of chronic lung disease
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Quinn (Edinburgh, United Kingdom), A. Pellicoro (Edinburgh, United Kingdom), C. Lochenie (Edinburgh, United Kingdom), E. Duffy (Edinburgh, United Kingdom), R. O'Connor (Edinburgh, United Kingdom), A. Fernando (Edinburgh, United Kingdom), H. Stewart (Edinburgh, United Kingdom), E. Gaughan (Edinburgh, United Kingdom), K. Finlayson (Edinburgh, United Kingdom), A. Mansell (Melbourne, Australia), C. Murphy (Concord, United States), A. Rossi (Edinburgh, United Kingdom), K. Dhaliwal (Edinburgh, United Kingdom). Dynamic microscopic imaging and molecular characterisation of alveolar macrophage drug effects of a labelled inflammasome inhibitor in the human lung. 3581
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|